Publication:
Markedwith Dyskeratosisoverlap of Congenitafour Geneticconfoundssyndromesclinical Diagnosis

dc.authorscopusid6601963147
dc.authorscopusid56242817700
dc.authorscopusid56625600000
dc.authorscopusid57189355860
dc.authorscopusid16402494600
dc.authorscopusid26435095000
dc.authorscopusid57099624400
dc.contributor.authorWalne, A.J.
dc.contributor.authorCollopy, L.
dc.contributor.authorCardoso, S.
dc.contributor.authorEllison, A.
dc.contributor.authorPlagnol, V.
dc.contributor.authorAlbayrak, C.
dc.contributor.authorAlbayrak, D.
dc.date.accessioned2020-06-21T13:32:01Z
dc.date.available2020-06-21T13:32:01Z
dc.date.issued2016
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Walne] Amanda J., Barts and The London School of Medicine and Dentistry, London, United Kingdom; [Collopy] Laura Catharine, Barts and The London School of Medicine and Dentistry, London, United Kingdom; [Cardoso] Shirleny Romualdo, Barts and The London School of Medicine and Dentistry, London, United Kingdom; [Ellison] Alicia C.M., Barts and The London School of Medicine and Dentistry, London, United Kingdom; [Plagnol] Vincent, University College London, London, United Kingdom; [Albayrak] Canan Uçar, Department of Pediatric Hematology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Albayrak] Davut, Department of Pediatric Hematology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Kiliç] Sara Şebnem, Bursa Uludağ Üniversitesi, Bursa, Bursa, Turkey; [Patirog̈lu] Türkan E., Erciyes Üniversitesi, Kayseri, Kayseri, Turkey; [Akar] Haluk, Erciyes Üniversitesi, Kayseri, Kayseri, Turkey; [Godfrey] Keith M., NIHR Southampton Biomedical Research Center, University Hospital Southampton NHS Foundation Trust, Southampton, Hampshire, United Kingdom; [Carter] Tina Louise, Department of Hematology and Oncology, Princess Margaret Hospital for Children, Perth, WA, Australia; [Marafie] Makia J., Clinical Cancer and Community Genetics, Kuwait Medical Genetics Centre, Safat, Kuwait; [Vora] Ajay J., Sheffield Children's NHS Foundation Trust, Sheffield, South Yorkshire, United Kingdom; [Sundin] Mikael C., Hematology/Immunology/SCT Section, Karolinska Universitetssjukhuset, Stockholm, Stockholms, Sweden, CLIN-TEC, Karolinska Institutet, Stockholm, Stockholms, Sweden; [Vulliamy] Tom J., Barts and The London School of Medicine and Dentistry, London, United Kingdom; [Tummala] Hemanth, Barts and The London School of Medicine and Dentistry, London, United Kingdom; [Dokal] Inderjeet S., Barts and The London School of Medicine and Dentistry, London, United Kingdomen_US
dc.description.abstractDyskeratosis congenita is a highly pleotropic genetic disorder. This heterogeneity can lead to difficulties in making an accurate diagnosis and delays in appropriate management. The aim of this study was to determine the underlying genetic basis in patients presenting with features of dyskeratosis congenita and who were negative for mutations in the classical dyskeratosis congenita genes. By whole exome and targeted sequencing, we identified biallelic variants in genes that are not associated with dyskeratosis congenita in 17 individuals from 12 families. Specifically, these were homozygous variants in USB1 (8 families), homozygous missense variants in GRHL2 (2 families) and identical compound heterozygous variants in LIG4 (2 families). All patients had multiple somatic features of dyskeratosis congenita but not the characteristic short telomeres. Our case series shows that biallelic variants in USB1, LIG4 and GRHL2, the genes mutated in poikiloderma with neutropenia, LIG4/Dubowitz syndrome and the recently recognized ectodermal dysplasia/short stature syndrome, respectively, cause features that overlap with dyskeratosis congenita. Strikingly, these genes also overlap in their biological function with the known dyskeratosis congenita genes that are implicated in telomere maintenance and DNA repair pathways. Collectively, these observations demonstrate the marked overlap of dyskeratosis congenita with four other genetic syndromes, confounding accurate diagnosis and subsequent management. This has important implications for establishing a genetic diagnosis when a new patient presents in the clinic. Patients with clinical features of dyskeratosis congenita need to have genetic analysis of USB1, LIG4 and GRHL2 in addition to the classical dyskeratosis congenita genes and telomere length measurements. © 2016 Ferrata Storti Foundation.en_US
dc.identifier.doi10.3324/haematol.2016.147769
dc.identifier.endpage1189en_US
dc.identifier.issn0390-6078
dc.identifier.issn1592-8721
dc.identifier.issue10en_US
dc.identifier.pmid27612988
dc.identifier.scopus2-s2.0-84989282799
dc.identifier.scopusqualityQ1
dc.identifier.startpage1180en_US
dc.identifier.urihttps://doi.org/10.3324/haematol.2016.147769
dc.identifier.volume101en_US
dc.identifier.wosWOS:000392548700019
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherFerrata Storti Foundationen_US
dc.relation.ispartofHaematologicaen_US
dc.relation.journalHaematologicaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleMarkedwith Dyskeratosisoverlap of Congenitafour Geneticconfoundssyndromesclinical Diagnosisen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files